CHMP2A directly interacts with ORF9b of SARS-CoV-2 (Gordon et al., 2020), which was found hyperactively expressed during infection but suppressed by IMD-0354 treatment (Figures 6E and 6F). The gene discussed is CHMP2A; the disease is infection.